Home
Alembic Pharmaceuticals Ltd Quarterly Result

Alembic Pharmaceuticals Ltd
NSE: APLLTD
Net Profit - Last Quarter
Alembic Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 1702 crore as compare to the Sep '24 revenue of ₹ 1678 crore.
- This represent the growth of 1.44%a1# The ebitda of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 270.08 crore as compare to the Sep '24 ebitda of ₹ 269.74 crore.
- This represent the growth of 0.13%a1# The net profit of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 137.7 crore as compare to the Sep '24 net profit of ₹ 153.14 crore.
- This represent the decline of -10.08%a1#.
Alembic Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Alembic Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
11 Apr 2025 | 847.4 |
09 Apr 2025 | 839.95 |
08 Apr 2025 | 850 |
07 Apr 2025 | 844.1 |
04 Apr 2025 | 881.8 |
03 Apr 2025 | 888.9 |
02 Apr 2025 | 885.2 |
01 Apr 2025 | 897.55 |
28 Mar 2025 | 929.25 |
27 Mar 2025 | 930.9 |
Historical Revenue of Alembic Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Alembic Pharmaceuticals Ltd
Historical EBITDA of Alembic Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Alembic Pharmaceuticals Ltd
Historical Net Profit of Alembic Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd News Hub
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f
Read more
13 Aug 24
Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa
Read more
13 Aug 24
Alembic Pharmaceuticals Ltd leads losers in 'A' group
Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t
Read more
09 Aug 24
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J
Read more
08 Aug 24
Document
Concalls
Feb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
Transcript